Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Rheumatology
•
Dermatology
•
Bullous/Blistering Skin Disorders
How often have you found patients complain about an infusion reaction to Remicade?
Related Questions
What is your stepwise approach to a patient with erosive gingivitis?
Does your institution have formal policies or work flows to reduce unnecessary IGRAs ordered for patients on biologics?
What treatments can be combined for the treatment of immune checkpoint inhibitor induced toxic epidermal necrolysis?
What is your approach to management of hyperlipidemia in patients taking JAK inhibitors?
Can Xolair (omalizumab) be safely used in combination with biologics for patients with rheumatic disease?
How would you approach the treatment of an SLE patient with refractory mucocutaneous ulcerations and lichenoid skin eruption despite treatment with MMF, Aza, Benlysta, Saphnelo, Rituximab, and JAK inhibitors?
What is your approach to treatment in patients with cutaneous mastocytosis and inflammatory arthritis?
What is your workup and management for patients with reactive perforating collagenosis?
How would you approach management of a young male patient with discoid lupus who has had minimal response to hydroxychloroquine (and subtherapeutic whole blood levels) who continues to use tobacco products?
Does the presence of psoriatic arthritis affect your decision to use an anti-IL-17 or IL-23 drug in your psoriasis patients?
